Delisting riskPopularity #4,337
GRI Bio (GRI)
Develops NKT-cell therapies for pulmonary fibrosis and autoimmune disease.
$2.08
vs last close+0.03 (+1.46%)
Something off on this page? Send us feedback.
Next report
Nov 13, 26
estimated · in 51 days
EPS estimate
−$0.84
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Aug '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$162.40−$162.40−$36.69−$35.85−$13.25−$1.61−$0.91Pending
Estimate−$105.98−$1.31−$36.69−$29.26−$29.27−$0.91−$1.19−$0.84
Surprise−53.2%−12,296.9%0.0%−22.5%+54.7%−76.9%+23.5%—
RevenueReportedEstimate
May '25Aug '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.92 | — | — |
| Sep 2027 | −$0.94 | — | — |
| Jun 2027 | −$0.96 | — | — |
| Mar 2027 | −$0.98 | — | — |
| Dec 2026 | −$0.83 | — | — |
| Nov 2026 | −$0.84 | — | — |
| Aug 2026 | −$1.19 | −$0.91 | +23.5% |
| May 2026 | −$0.91 | −$1.61 | −76.9% |
| Mar 2026 | −$29.27 | −$13.25 | +54.7% |
| Nov 2025 | −$29.26 | −$35.85 | −22.5% |
| Aug 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Sep 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Dec 2022 | |||
| Nov 2022 | |||
| Jul 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.92 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.94 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.96 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.98 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.83 | — | — | $0 | — | — | — |
| Nov 13, 2026 | −$0.84 | — | — | $0 | — | — | — |
| Aug 14, 2026 | −$1.19 | −$0.91 | +23.5% | — | — | — | −5.7% |
| May 13, 2026 | −$0.91 | −$1.61 | −76.9% | — | — | — | −0.9% |
| Mar 13, 2026 | −$29.27 | −$13.25 | +54.7% | — | — | — | +0.4% |
| Nov 14, 2025 | −$29.26 | −$35.85 | −22.5% | — | — | — | 0.0% |
| Aug 14, 2025 | |||||||
| Aug 12, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 17, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Sep 16, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 10, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Feb 24, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Nov 3, 2022 | |||||||
| Jul 28, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 14, 2022 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |